Get the content you want anytime you want.
REGISTER NOW | SIGN IN
2019 Annual MAD-ID Meeting

Select coverage from 2019 Annual MAD-ID Meeting is included below:

Time to Clinical Response as a Valuable Metric
Thomas Lodise, PharmD, PhD, discusses why "time to clinical response" is a valuable metric to use in clinical studies.
Why ID? Experts Share The 'Why' That Drove Them to Pursue Infectious Disease Careers
We asked providers in the field why they pursued a career in infectious disease.
Alison Lew, PharmD: Vancomycin Prophylaxis for CDI Recurrence
At MAD-ID 2019, Alison Lew, PharmD, spoke about her research on oral vancomycin prophylaxis to reduce CDI recurrence. 
Renee Ackley, PharmD, BCPS: Comparing Agents for Treating CRE
Renee Ackley, PharmD, BCPS, discusses her research ceftazidime/avibactam and meropenem/vaborbactam for treatment of CRE infections.
Amy Fabian, PharmD, BCPS: Pharmacist Impact on Antimicrobial Prescribing in Outpatient Setting
Does pharmacist presence in an urgent care center have an effect on antibiotic prescribing practices?
Jason Gallagher, PharmD, on New Gram-Negative Agents and Practical Micro Lab Interventions
Contagion® editor-in-chief Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, recaps his presentations from MAD-ID 2019. 
Exploring Outcomes of Extended Infusions for Gram-Negative Bacteremia
As clinician are growing interested in the use of extended infusion beta-lactams for gram-negative bacteremia, a team of investigators noticed that available data are unclear and solely focus on clinical cure and/or mortality outcomes.
Monica V. Mahoney, PharmD, BCPS (AQID), BCIDP, on Formulary Management Strategies
At MAD-ID 2019, Monica V. Mahoney, PharmD, BCPS (AQID), BCIDP, presented a workshop on formulary management strategies in antimicrobial stewardship.
FEATURED
Big advances in treatment can't make up for an inability to stop new infections, which number 5,000 per day worldwide.